Additionally, it can promote the proliferation of osteosarcoma by inhibiting the expression of P21 and upregulate the level of Cyclin D1, CyclinE1, CDK2, and CDK6, which drives G0/G1 to the G2/M phase transition. Here, CCND1 is linked to osteosarcoma.